DermTech, Inc.

DMTKQ Healthcare Diagnostics & Research

DermTech, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $15.3 million, up 5.36% from fiscal 2022. Revenue growth for five consecutive years, operating cash flow growth for three.

0.00 0.00 NaN
Market cap
$3.3M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
3/9
Altman Z
−6.55
Beneish M
−2.88
Dividend safety
n/a
Older periods Jun '23 Sep '23 Dec '23 Mar '24
Piotroski F-Score

+8 more TTM periods

3 3 3 4
ROE
(89.73%) (96.49%) (106.46%) (121.75%)
ROA
(64.11%) (66.29%) (62.28%) (64.00%)
ROIC
(3,954.90%) (1,437.56%) (4,806.29%) (5,493.45%)
Return on Tangible Assets
(142.75%) (159.67%) (189.31%) (247.73%)
Average Days of Receivables
100.59 91.59 61.66 58.18
Free Cash Flow per Share
(2.96) (2.62) (2.39) (2.08)
Free Cash Flow
(94.22) (88.50) (77.88) (72.07)
Other line items

Show all line items

Columns are period end dates